# Hims & Hers struck a GLP-1 deal with Lilly. Its stock is rallying.

- Source: MarketWatch Top Stories
- Published: 2026-11-06T16:29:00+00:00
- Category: Markets
- Original: https://www.marketwatch.com/story/hims-hers-struck-a-glp-1-deal-with-lilly-its-stock-is-rallying-d06ebe60?mod=mw_rss_topstories
- Canonical: https://groundlevelnews.com/story/hims-hers-struck-a-glp-1-deal-with-lilly-its-stock-is-rallying-017519/

As part of the agreement, Hims said it won’t compound GLP-1 medications like Zepbound in the future.

_Ground Level News shows a short summary only; the full article and all rights belong to MarketWatch Top Stories._